Jan De Bleecker

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study

Ilse Gijselinck, Tim Van Langenhove, Julie van der Zee et al. · The Lancet Neurology · 2011 · 628 citations

Life Sciences, Genetics, Molecular Genetics +16

224th ENMC International Workshop:

Yves Allenbach, Andrew L. Mammen, Olivier Benvéniste et al. · Neuromuscular Disorders · 2017 · 554 citations · Full text

Computing, Mechanical Engineering, Global Navigation Satellite Systems +1

The genetic causes of basal ganglia calcification, dementia, and bone cysts

Hans H. Klünemann, Basil H. Ridha, Laurent Magy et al. · Neurology · 2005 · 263 citations

Medicine, Genetics, Neurology +15

Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients

Mathieu Anheim, B. Monga, Marie‐Céline Fleury et al. · Brain · 2009 · 248 citations · Full text

Life Sciences, Genetics, Neurology +14